NCT03538054View on ClinicalTrials.gov

Dextromethorphan in Fibromyalgia

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

June 26, 2018

Primary Completion Date

March 18, 2020

Study Completion Date

March 18, 2020

Conditions
Fibromyalgia
Interventions
DRUG

Dextromethorphan

(1)10 mg, by mouth, twice daily every 12 hours.

DRUG

Placebo

1 capsule, by mouth, twice daily every 12 hours.

Trial Locations (1)

35294

University of Alabama of Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT03538054 - Dextromethorphan in Fibromyalgia | Biotech Hunter | Biotech Hunter